John R Stuelpnagel sold $1.2M of TXG
director at 10x Genomics, Inc.. 20,000 shares at an average of $61.75, traded Sep 3, 2026, filed Sep 8, 2026.
Score components
- +15RoleDirector
- +25Trade size$1.2M at market
- 0Share of holdings soldSold 5.7% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001610717-26-000405, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | SOpen-market sale Class A Common Stock | -7,012 | $60.66 | $425k | 341,424 | 34 d ago |
| Sep 3, 2026 | SOpen-market sale Class A Common Stock | -6,814 | $62.11 | $423k | 334,610 | 34 d ago |
| Sep 3, 2026 | SOpen-market sale Class A Common Stock | -6,174 | $62.61 | $387k | 328,436 | 34 d ago |
Related signals
Other insiders at 10x Genomics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | 10x Genomics, Inc. | Serge Saxonov Chief Executive Officer | $2.0M 25,000 shares | -2% | |
| 32Weak | 10x Genomics, Inc. | Shehnaaz Suliman director | $465k 5,723 shares | -19% | |
| 47Moderate | 10x Genomics, Inc. | Adam Taich Chief Financial Officer | $3.0M 46,388 shares | -13% | |
| 19Weak | 10x Genomics, Inc. | Serge Saxonov Chief Executive Officer | $289k 15,000 shares | -1% | |
| 35Weak | 10x Genomics, Inc. | Serge Saxonov Chief Executive Officer | $367k 16,152 shares | -1% | |
| 26Weak | 10x Genomics, Inc. | Sarah A. Teichmann director | $147k 7,579 shares | -22% | |
| 41Moderate | 10x Genomics, Inc. | Benjamin J. Hindson See Remarks | $145k 7,826 shares | -2% | |
| 48Moderate | 10x Genomics, Inc. | Adam Taich Chief Financial Officer | $167k 8,968 shares | -3% | |
| 52Moderate | 10x Genomics, Inc. | Serge Saxonov Chief Executive Officer | $179k 9,632 shares | -1% | |
| 53Moderate | 10x Genomics, Inc. | Serge Saxonov Chief Executive Officer | $252k 13,261 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.